Wockhardt is amongst the leading pharmaceutical and biotechnology companies based out of India, with a market capitalization of $ 1.2 billion. With a strong Global footprint, today almost 60% of Wockhardt's turnover comes out of International markets, most of it from Europe and the US.

Established nearly four decades ago, Wockhardt has built up a strong presence in the Healthcare business encompassing pharmaceutical formulations, bulk actives, biopharmaceuticals, vaccines and infant nutrition. Wockhardt is the only Indian pharmaceutical company to be selected as business “Superbrand” This "title" was awarded to Wockhardt by The Superbrands Council in recognition for offering consumers emotional and tangible benefits.

Wockhardt was rated among the Top 15 value creators (Source: Business World Nov '03) in India and has a consistent track record of growth in sales (21% CAGR) and profitability (22% CAGR) over the last 10 years. Currently, Wockhardt has a consolidated group turnover of over USD 300 mn.

All Wockhardt plants including Sterile, API and Formulations are approved by various international regulatory authorities like USFDA, UK MHRA, Australian TGA etc.

Address

Wochardt Hospital & Heart Instit
14,Cunningham Road, Vasanth Nagar
Bangalore - 560052
080 22261037